Page last updated: 2024-09-02

saikosaponin d and Cytokine Release Syndrome

saikosaponin d has been researched along with Cytokine Release Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bahbah, EI; Nabet, MS; Negida, A	1

Other Studies

1 other study(ies) available for saikosaponin d and Cytokine Release Syndrome

Article	Year
Purposing Saikosaponins for the treatment of COVID-19. Medical hypotheses, 2020, Volume: 140 Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Repositioning; Humans; Immunologic Factors; Lymphocyte Activation; Molecular Docking Simulation; Oleanolic Acid; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; Saponins; SARS-CoV-2	2020

Article

Year

Purposing Saikosaponins for the treatment of COVID-19.

Medical hypotheses, 2020, Volume: 140

Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Repositioning; Humans; Immunologic Factors; Lymphocyte Activation; Molecular Docking Simulation; Oleanolic Acid; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; Saponins; SARS-CoV-2

2020